Abstract
A meta-analysis was recently published based on six randomized clinical trials of at least one year duration involving finasteride 5 mg and placebo in the treatment of men with clinical benign prostatic hyperplasia (BPH). In a pooled analysis, mean improvement in symptoms and urinary flow rate with finasteride were found to increase with increasing prostate size. This article reviews the previous publication of this meta-analysis, which indicated prostate volume is a key predictor of outcomes with finasteride treatment and suggested that finasteride is most effective in men with large prostates.
Original language | English (US) |
---|---|
Pages (from-to) | 46-49 |
Number of pages | 4 |
Journal | Urology |
Volume | 51 |
Issue number | 4 SUPPL. A |
DOIs | |
State | Published - Apr 1998 |
ASJC Scopus subject areas
- Urology